The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Published online August 10, 2009
The Journal of Immunology, 2009, 183, 3237 -3248
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0901548

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jimmunol.0901548v1
183/5/3237    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kuraoka, M.
Right arrow Articles by Ueda, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuraoka, M.
Right arrow Articles by Ueda, Y.

Activation-Induced Cytidine Deaminase Expression and Activity in the Absence of Germinal Centers: Insights into Hyper-IgM Syndrome1

Masayuki Kuraoka*, Dongmei Liao*, Kaiyong Yang*, Sallie D. Allgood{dagger}, Marc C. Levesque{dagger}, Garnett Kelsoe2,* and Yoshihiro Ueda*

* Department of Immunology and {dagger} Department of Medicine, Duke University, Durham, NC 27710

Somatic hypermutation normally occurs as a consequence of the expression of activation-induced cytidine deaminase (AID) by Ag-activated, mature B cells during T cell-dependent germinal center responses. Nonetheless, despite their inability to express CD154 and initiate GC responses, patients with type 1 hyper-IgM syndrome (HIGM1) support populations of IgM+IgD+CD27+ B cells that express mutated Ig genes. The origin of these mutated B cells is unknown; the IgM+IgD+CD27+ cells do not express AID and appear to acquire mutations independent of stringent selection by Ag. Here, we demonstrate that immature/transitional 1 B cells from the bone marrow of CD154-deficient mice express AID and acquire Ig mutations that lack the hallmarks of antigenic selection via BCR signaling. Comparable levels of AID expression was found in developmentally immature B cells recovered from murine fetal liver and from human immature/transitional 1 B cells recovered from umbilical cord blood. AID expression in human fetal liver was also robust, approaching that of human tonsil tissue and the human germinal center B cell line, Ramos. These observations led us to conclude that AID expression in developing human B cells is the origin of the mutated IgM+IgD+CD27+ B cells present in HIGM1 patients, and we propose that both mice and humans share a latent, AID-dependent pathway for the preimmune diversification of B lymphocytes that is more prominent in chicken, sheep, and rabbits.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by the Bill and Melinda Gates Foundation and National Institutes of Health Grants AI024335, AI056363 (to G.K.), and AI066106 (to M.L.).

2 Address correspondence and reprint requests to Dr. Garnett Kelsoe, Department of Immunology, Duke University, Durham, NC 27710. E-mail address: ghkelsoe{at}duke.edu

3 Abbreviations used in this paper: SHM, somatic hypermutation; AID, activation-induced cytidine deaminase; AMuLV, Abelson murine leukemia virus; BL/6, C57BL/6; BM, bone marrow; CGG, chicken {gamma}-globulin; CSR, class-switch recombination; GC, germinal center; HIGM1, type-1 hyper IgM syndrome; im/T1, immature/transitional 1; MF, mature follicular; MZ, marginal zone; NIP, (4-hydroxy-5-iodo-3-nitrophenyl)acetyl; NP, (3-hydroxy-4-nitrophenyl)acetyl; PP, Peyer’s patch; Td, T cell-dependent; Ti, T cell-independent; T2, transitional 2.

4 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.